Completed PHASE3 INTERVENTIONAL 2-arm NCT01580839

EXTEND (International): Extending the Time for Thrombolysis in Emergency Neurological Deficits (International) (EXTEND)

Extending the Time for Thrombolysis in Emergency Neurological Deficits

Sponsor: China Medical University Hospital

Conditions Stroke

Interventions Placebo Tissue Plasminogen Activator (Alteplase)

Updated 8 times since 2017 Last updated: Aug 30, 2018 Started: Dec 6, 2012 Primary completion: Aug 22, 2018 Completion: Aug 22, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Stroke, this trial is completed. The trial is conducted by China Medical University Hospital and has accumulated 8 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Sep 2018 — Jan 2021 [monthly]

Completed PHASE3

Status: Active Not Recruiting → Completed
Aug 2018 — Sep 2018 [monthly]

Active Not Recruiting PHASE3

Status: Recruiting → Active Not Recruiting

▶ Show 3 earlier versions

Jun 2018 — Aug 2018 [monthly]

Recruiting PHASE3
Jan 2018 — Jun 2018 [monthly]

Recruiting PHASE3
Jan 2017 — Jan 2018 [monthly]

Recruiting PHASE3

First recorded

Dec 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

China Medical University Hospital
Neuroscience Trials Australia

Data source: Neuroscience Trials Australia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taichung, Taiwan